ES2083348T1 - Derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il)-metoxi-1,3-propandiol. - Google Patents
Derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il)-metoxi-1,3-propandiol.Info
- Publication number
- ES2083348T1 ES2083348T1 ES95111319T ES95111319T ES2083348T1 ES 2083348 T1 ES2083348 T1 ES 2083348T1 ES 95111319 T ES95111319 T ES 95111319T ES 95111319 T ES95111319 T ES 95111319T ES 2083348 T1 ES2083348 T1 ES 2083348T1
- Authority
- ES
- Spain
- Prior art keywords
- metoxi
- dihidro
- purin
- oxo
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE PRESENTAN UN ESTER DE L-MONOVALINA DERIVADO DEL 2-(2-AMINO1,6-DIHIDRO-6-OXO-PURIN-9-YL)METOXI-1,3-PROPANEDIOL Y SUS SALES FARMACOLOGICAMENTE ACEPTABLES QUE TIENEN VALOR COMO AGENTES ANTIVIRALES CON UNA ABSORCION MEJORADA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28189394A | 1994-07-28 | 1994-07-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2083348T1 true ES2083348T1 (es) | 1996-04-16 |
ES2083348T3 ES2083348T3 (es) | 1999-08-01 |
Family
ID=23079211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95111319T Expired - Lifetime ES2083348T3 (es) | 1994-07-28 | 1995-07-19 | Derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il)metoxi-1,3-propandiol. |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP0694547B1 (es) |
JP (1) | JP3090305B2 (es) |
KR (1) | KR100358626B1 (es) |
CN (1) | CN1045089C (es) |
AT (1) | ATE179173T1 (es) |
AU (1) | AU697107B2 (es) |
BR (1) | BR9503468A (es) |
CA (1) | CA2154721C (es) |
CO (1) | CO4410181A1 (es) |
CY (2) | CY2180B1 (es) |
CZ (1) | CZ290511B6 (es) |
DE (3) | DE10299032I2 (es) |
DK (1) | DK0694547T3 (es) |
ES (1) | ES2083348T3 (es) |
FI (1) | FI112080B (es) |
GR (2) | GR960300021T1 (es) |
HK (1) | HK1012339A1 (es) |
HU (1) | HU216867B (es) |
IL (1) | IL114735A (es) |
LU (1) | LU91136I2 (es) |
MA (1) | MA23631A1 (es) |
MY (1) | MY114393A (es) |
NL (1) | NL300071I2 (es) |
NO (2) | NO312899B1 (es) |
NZ (1) | NZ272652A (es) |
PE (1) | PE32296A1 (es) |
PL (1) | PL180609B1 (es) |
RU (1) | RU2133749C1 (es) |
SA (1) | SA95160158B1 (es) |
TR (1) | TR199500895A2 (es) |
TW (1) | TW434242B (es) |
UY (1) | UY24006A1 (es) |
ZA (1) | ZA956228B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
WO1997027194A1 (en) * | 1996-01-26 | 1997-07-31 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
ATE222909T1 (de) * | 1996-01-26 | 2002-09-15 | Hoffmann La Roche | Verfahren zur herstellung von purin-derivaten |
US5756736A (en) * | 1996-01-26 | 1998-05-26 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US5700936A (en) * | 1996-01-26 | 1997-12-23 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate |
US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US6703394B2 (en) | 1996-02-16 | 2004-03-09 | Medivir Ab | Acyclic nucleoside derivatives |
US5869493A (en) | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
CA2572577C (en) * | 1997-02-10 | 2011-04-05 | Medivir Ab | Synthesis of acyclic nucleoside derivatives |
US6184376B1 (en) | 1997-02-10 | 2001-02-06 | Mediver Ab | Synthesis of acyclic nucleoside derivatives |
PT988304E (pt) * | 1997-08-15 | 2001-10-31 | Medivir Ab | Analogos de nucleosidos tais como os antivirais que contem inibidores de transcritase reversa retroviral e de adn-polimerase do virus da hepatite b (hbv) |
AU1711599A (en) * | 1997-12-19 | 1999-07-12 | Bristol-Myers Squibb Company | Prodrugs of lobucavir and methods of use |
WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
KR20030015655A (ko) * | 2001-08-17 | 2003-02-25 | 한미약품공업 주식회사 | 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물 |
DE60328675D1 (de) * | 2002-04-23 | 2009-09-17 | Aventis Pharma Inc | 3-(substitutierte amino)-1h-indole-2-carbonsäureester und 3-(substitutierte amino)-benzoäbüthiophen-2-carbonsäureester verbindungen als inhibitoren der interleukin-4 genexpression |
AU2003273000A1 (en) | 2002-10-16 | 2004-05-04 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
US20040224916A1 (en) | 2003-01-14 | 2004-11-11 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
EP1660499A1 (en) * | 2003-08-28 | 2006-05-31 | Ranbaxy Laboratories Limited | Amorphous valganciclovir hydrochloride |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
NZ553263A (en) * | 2004-07-19 | 2010-06-25 | Biocon Ltd | Insulin-oligomer conjugates, formulations and uses thereof |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
ZA200702234B (en) * | 2006-03-21 | 2008-07-30 | Cipla Ltd | Preparation of ester of purine derivatives |
CN102014638A (zh) | 2007-10-12 | 2011-04-13 | 武田制药北美公司 | 与食物摄入无关的治疗胃肠病症的方法 |
EP2714691B1 (en) * | 2011-05-31 | 2016-09-07 | Pharmathen S.A. | Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir |
KR102312533B1 (ko) | 2021-02-24 | 2021-10-15 | 주식회사 이웅 | 자동 스패너 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8202626A (nl) * | 1982-06-29 | 1984-01-16 | Stichting Rega V Z W | Derivaten van 9-(2-hydroxyethoxymethyl)guanine. |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
FI91959C (fi) * | 1984-12-12 | 1994-09-12 | Syntex Inc | Menetelmä valmistaa alkoksimetyylieetteri- ja alkoksimetyyliesterijohdoksia |
AP55A (en) * | 1987-08-15 | 1989-09-26 | The Wellcome Foundation Ltd | Therapeutic Acyclic Nucleosides |
JP2788084B2 (ja) * | 1988-12-19 | 1998-08-20 | ザ ウエルカム フアウンデーシヨン リミテツド | 抗ウイルス化合物 |
-
1995
- 1995-07-10 PE PE1995273436A patent/PE32296A1/es not_active IP Right Cessation
- 1995-07-19 DK DK95111319T patent/DK0694547T3/da active
- 1995-07-19 DE DE2002199032 patent/DE10299032I2/de active Active
- 1995-07-19 ES ES95111319T patent/ES2083348T3/es not_active Expired - Lifetime
- 1995-07-19 DE DE69509173T patent/DE69509173T2/de not_active Expired - Lifetime
- 1995-07-19 AT AT95111319T patent/ATE179173T1/de active
- 1995-07-19 DE DE0694547T patent/DE694547T1/de active Pending
- 1995-07-19 EP EP95111319A patent/EP0694547B1/en not_active Expired - Lifetime
- 1995-07-21 TR TR95/00895A patent/TR199500895A2/xx unknown
- 1995-07-26 IL IL114735A patent/IL114735A/en not_active IP Right Cessation
- 1995-07-26 AU AU27195/95A patent/AU697107B2/en not_active Expired
- 1995-07-26 MA MA23971A patent/MA23631A1/fr unknown
- 1995-07-26 ZA ZA956228A patent/ZA956228B/xx unknown
- 1995-07-26 HU HU9502238A patent/HU216867B/hu unknown
- 1995-07-26 CA CA002154721A patent/CA2154721C/en not_active Expired - Lifetime
- 1995-07-26 NZ NZ272652A patent/NZ272652A/en not_active IP Right Cessation
- 1995-07-27 TW TW084107779A patent/TW434242B/zh not_active IP Right Cessation
- 1995-07-27 UY UY24006A patent/UY24006A1/es not_active IP Right Cessation
- 1995-07-27 PL PL95309812A patent/PL180609B1/pl unknown
- 1995-07-27 RU RU95113148A patent/RU2133749C1/ru active
- 1995-07-27 NO NO19952977A patent/NO312899B1/no not_active IP Right Cessation
- 1995-07-27 FI FI953592A patent/FI112080B/fi active Protection Beyond IP Right Term
- 1995-07-27 KR KR1019950022600A patent/KR100358626B1/ko not_active IP Right Cessation
- 1995-07-27 CN CN95109671A patent/CN1045089C/zh not_active Expired - Lifetime
- 1995-07-27 JP JP07190953A patent/JP3090305B2/ja not_active Expired - Lifetime
- 1995-07-27 BR BR9503468A patent/BR9503468A/pt active Search and Examination
- 1995-07-27 CO CO95033418A patent/CO4410181A1/es unknown
- 1995-07-27 MY MYPI95002156A patent/MY114393A/en unknown
- 1995-07-27 CZ CZ19951939A patent/CZ290511B6/cs not_active IP Right Cessation
- 1995-08-14 SA SA95160158A patent/SA95160158B1/ar unknown
-
1996
- 1996-04-30 GR GR960300021T patent/GR960300021T1/el unknown
-
1998
- 1998-12-15 HK HK98113443A patent/HK1012339A1/xx not_active IP Right Cessation
-
1999
- 1999-07-02 GR GR990401760T patent/GR3030678T3/el unknown
-
2000
- 2000-08-10 CY CY0000039A patent/CY2180B1/xx unknown
-
2001
- 2001-11-23 NL NL300071C patent/NL300071I2/nl unknown
-
2003
- 2003-01-10 NO NO2003001C patent/NO2003001I2/no unknown
- 2003-05-21 LU LU91136C patent/LU91136I2/fr unknown
-
2004
- 2004-10-20 CY CY200400003C patent/CY2004003I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2083348T3 (es) | Derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il)metoxi-1,3-propandiol. | |
BR9801775B1 (pt) | fibra àptica tendo uma inclinaÇço de dispersço baixa na regiço de amplificador de Érbio. | |
DE60021099D1 (de) | Transdermale, in form einer haftschicht ausgebildete zweifachmedikamenten-verabreichungsvorrichtung | |
DE60143477D1 (de) | Verminderung der nebenwirkungen bei der oxybutynin-therapie | |
FI915152A (fi) | Synergism hos inhibitorer foer reverserade transkriptaser i hiv. | |
MX9300550A (es) | Estructura de fibra absorbente. | |
TR28377A (tr) | Lif cekme jetlerinin temizlenmesi. | |
DE69114684D1 (de) | Faserschlichtemittel. | |
ES2105074T3 (es) | Compuestos basados en 3,4-diaril-(5h)-furan-2-ona, con actividad fungicida. | |
DK0458589T3 (da) | Behandling af okulær hypertension med en okulær synergistisk kombination | |
GT199500039BA (es) | Compuestos ariltios | |
DK0612469T3 (da) | Præparat med akaricid virkning | |
AR027349A1 (es) | Derivados de amidas heterociclicas | |
FR2795878B1 (fr) | Source laser avec filtrage integre de l'emission spontanee amplifiee | |
ES2033620T1 (es) | Apero de cultivo del suelo. | |
ES2189108T3 (es) | Nuevas oxazinas dissustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
ES2107607T3 (es) | Tiazolilpirroles que tienen una actividad fungicida. | |
DE69107160D1 (de) | Stromversorgungsanordnung. | |
ECSP951495A (es) | Derivado de 2-(2-amino-1,6- dihidro-6-oxo- purin-9-il) metoxi-1,3- propan-diol | |
ES2049696T3 (es) | Utilizacion de una amida como agente espesante y composicion que la contiene. | |
ES1043884Y (es) | Butaca con mesa de trabajo posterior. | |
ITTO910671A1 (it) | Procedimento per effettuare una saldatura laser con effetto estetico del giunto. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 694547 Country of ref document: ES |
|
SPCF | Request for supplementary protection certificate filed |
Free format text: VALGANCICLOVIR (VALCYTE) Spc suppl protection certif: C200200029 Filing date: 20021113 |
|
SPCG | Supplementary protection certificate granted |
Free format text: VALGANCICLOVIR (VALCYTE) Spc suppl protection certif: C200200029 Filing date: 20021113 Expiry date: 20160920 Effective date: 20040309 |